Michele Sanicola

Genesys (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index4.3kcitations35works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Developmental Biology and Gene Regulation(9), TGF-β signaling in diseases(8), Cell Adhesion Molecules Research(5), Wnt/β-catenin signaling in development and cancer(5), Renal and related cancers(5)

Publications35 total

Abstract 3819: INCAGN02385 is an antagonist antibody targeting the co-inhibitory receptor LAG-3 for the treatment of human malignancies
Cancer Research·2018· 24 cited
RON<i>(MST1R)</i>is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
Cancer Biology & Therapy·2011· 103 cited
An antibody–cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours
European Journal of Cancer·2011· 42 cited
CRIPTO3, a presumed pseudogene, is expressed in cancer
Biochemical and Biophysical Research Communications·2008· 29 cited
Growth Factor Induction of Cripto-1 Shedding by Glycosylphosphatidylinositol-Phospholipase D and Enhancement of Endothelial Cell Migration
Journal of Biological Chemistry·2007· 68 citedOpen Access
Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma
Oncogene·2005· 73 citedOpen Access
Role of Human Cripto-1 in Tumor Angiogenesis
JNCI Journal of the National Cancer Institute·2005· 80 citedOpen Access
Nodal and Cripto-1: Embryonic Pattern Formation Genes Involved in Mammary Gland Development and Tumorigenesis
Journal of Mammary Gland Biology and Neoplasia·2004· 41 cited
Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV‐Cripto‐1 transgenic mice
Journal of Cellular Physiology·2004· 133 cited
Cripto‐1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF‐7 breast cancer cells
Journal of Cellular Physiology·2003· 64 cited
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo
Journal of Clinical Investigation·2003· 155 citedOpen Access
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo
Journal of Clinical Investigation·2003· 8 cited
The CRIPTO/FRL‐1/CRYPTIC (CFC) domain of human Cripto
European Journal of Biochemistry·2003· 19 citedOpen Access
Erratum: A nodal- and ALK4-independent signaling pathway activated by cripto-1 through glypican-1 and c-Src, (Cancer Research (March 15, 2003) (1192-1197))
Cancer Research·2003
A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
PubMed·2003· 105 cited
Shedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration
Journal of Biological Chemistry·2002· 341 citedOpen Access
Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial Cells
Molecular and Cellular Biology·2002· 146 citedOpen Access
Detection and localization of Cripto‐1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin–cripto‐1 fusion protein†
Journal of Cellular Physiology·2001· 22 cited
Nmb, a PKD domain protein, is highly expressed in macrophages during early development and in the kidney after renal ischemia
Journal of the American Society of Nephrology 12(Program and Abstract Issue)·2001
Fucosylation of Cripto Is Required for Its Ability to Facilitate Nodal Signaling
Journal of Biological Chemistry·2001· 90 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

David S. Salomon(12), Caterina Bianco(11), Nicola Normanno(11), Heather B. Adkins(10), Christian Wechselberger(9), Richard L. Cate(8), Nadia Khan(8), Olivia Orozco(7), Youping Sun(7), Luigi Strizzi(7), Kevin P. Williams(6), Antonella De Luca(5), Masaharu Seno(5), Morihisa Hirota(5), Véronique Bailly(4), Catherine Hession(4), Anne E. Cheung(4), Dian L. Olson(4), Konrad Miatkowski(4), Andreas D. Ebert(4)